MBX Biosciences, Inc. 8-K

What Happened
MBX Biosciences, Inc. announced in a Form 8-K filed June 5, 2026 that it held its 2026 annual meeting of stockholders on June 4, 2026 and that stockholders approved the election of two Class II directors. The elected directors will serve three-year terms expiring at the company’s 2029 annual meeting. The actions are reported under Items 5.02 and 5.07 of the Form 8-K.

Key Details

• Annual meeting date: June 4, 2026; Form 8-K filed June 5, 2026.
• Stockholders approved election of two Class II directors.
• Term length: three years, ending at the annual meeting in 2029.
• Reported under Items 5.02 (departure/election of directors/officers) and 5.07 (submission of matters to a vote of security holders).

Why It Matters
Board composition and director elections are governance events investors watch because directors influence oversight, strategy, and management accountability. These election results confirm the board’s Class II membership through 2029 and are part of MBX’s corporate governance record disclosed to investors.